NASDAQ:INHX - Inhibitex Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Inhibitex (NASDAQ:INHX)

Inhibitex logoInhibitex, Inc. develops antibody-based products for the treatment and prevention of bacterial and fungal infections. The Company produces products that can be used as vaccines, binding inhibitors or separation supports for affinity purifications. The Company's lead product candidate, Veronate, which entered into Phase III clinical trial in the second half of 2004, is being developed for the prevention of hospital-associated infections in premature, very low birth weight, (VLBW) infants.

Receive INHX News and Ratings via Email

Sign-up to receive the latest news and ratings for INHX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Inhibitex (NASDAQ:INHX) Frequently Asked Questions

What is Inhibitex's stock symbol?

Inhibitex trades on the NASDAQ under the ticker symbol "INHX."

Who are some of Inhibitex's key competitors?

Has Inhibitex been receiving favorable news coverage?

Press coverage about INHX stock has been trending somewhat negative this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Inhibitex earned a news impact score of -0.06 on Accern's scale. They also assigned news articles about the healthcare company an impact score of 45.64 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Inhibitex?

Shares of INHX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Inhibitex?

Inhibitex's mailing address is 9005 Westside Pkwy, ALPHARETTA, GA 30009-4783, United States. The healthcare company can be reached via phone at +1-678-7461100.

MarketBeat Community Rating for Inhibitex (INHX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  104 (Vote Outperform)
Underperform Votes:  75 (Vote Underperform)
Total Votes:  179
MarketBeat's community ratings are surveys of what our community members think about Inhibitex and other stocks. Vote "Outperform" if you believe INHX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INHX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Inhibitex (NASDAQ:INHX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/23/2016 forward)


Inhibitex (NASDAQ:INHX) Earnings History and Estimates Chart

Earnings by Quarter for Inhibitex (NASDAQ:INHX)

Inhibitex (NASDAQ INHX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2011Q3 2011($0.09)($0.07)ViewN/AView Earnings Details
8/8/2011Q2 2011($0.09)($0.07)ViewN/AView Earnings Details
5/6/2011Q1 2011($0.11)($0.12)ViewN/AView Earnings Details
3/11/2011Q4 2010($0.09)($0.11)ViewN/AView Earnings Details
11/9/2010Q3 2010($0.09)($0.08)ViewN/AView Earnings Details
8/10/2010Q2 2010($0.10)($0.09)ViewN/AView Earnings Details
5/13/2010Q1 2010($0.08)($0.08)ViewN/AView Earnings Details
3/23/2010Q4 2009($0.09)($0.08)ViewN/AView Earnings Details
11/6/2009Q3 2009($0.11)($0.10)ViewN/AView Earnings Details
8/11/2009Q2 2009($0.10)($0.10)ViewN/AView Earnings Details
5/12/2009Q1 2009($0.07)($0.10)ViewN/AView Earnings Details
3/13/2009Q4 2008($0.10)($0.08)ViewN/AView Earnings Details
11/7/2008Q3 2008($0.10)($0.09)ViewN/AView Earnings Details
8/12/2008Q2 2008($0.10)($0.05)ViewN/AView Earnings Details
5/8/2008Q1 2008($0.10)($0.08)ViewN/AView Earnings Details
3/7/2008Q4 2007($0.11)($0.08)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Inhibitex (NASDAQ:INHX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Inhibitex (NASDAQ INHX) Insider Trading and Institutional Ownership History

Insider Trading History for Inhibitex (NASDAQ:INHX)

Inhibitex (NASDAQ INHX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


Inhibitex (NASDAQ INHX) News Headlines

No headlines for this company have been tracked by

SEC Filings

Inhibitex (NASDAQ:INHX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Inhibitex (NASDAQ:INHX) Income Statement, Balance Sheet and Cash Flow Statement


Inhibitex (NASDAQ INHX) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.